Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 544

1.

Calcium-channel blockers reduce the antiplatelet effect of clopidogrel.

Siller-Matula JM, Lang I, Christ G, Jilma B.

J Am Coll Cardiol. 2008 Nov 4;52(19):1557-63. doi: 10.1016/j.jacc.2008.07.055.

PMID:
19007592
[PubMed - indexed for MEDLINE]
Free Article
2.

[Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].

Morel O, Viellard C, Faure A, Jesel L, Ohlmann P, Desprez D, Chauvin M, Roul G, Grunebaum L, Bareiss P.

Ann Cardiol Angeiol (Paris). 2007 Jan;56(1):21-9. French.

PMID:
17343035
[PubMed - indexed for MEDLINE]
3.

The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.

Harmsze AM, Robijns K, van Werkum JW, Breet NJ, Hackeng CM, Ten Berg JM, Ruven HJ, Klungel OH, de Boer A, Deneer VH.

Thromb Haemost. 2010 May;103(5):920-5. doi: 10.1160/TH09-08-0516. Epub 2010 Mar 29.

PMID:
20352154
[PubMed - indexed for MEDLINE]
4.

Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.

Heart. 2010 Feb;96(3):186-9. doi: 10.1136/hrt.2009.171488. Epub 2009 Aug 16.

PMID:
19687016
[PubMed - indexed for MEDLINE]
5.

Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".

Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, Kala P; PRAGUE-8 Study Investigators.

J Cardiovasc Pharmacol. 2009 May;53(5):368-72. doi: 10.1097/FJC.0b013e31819d616b.

PMID:
19247187
[PubMed - indexed for MEDLINE]
6.

The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis.

Blindt R, Stellbrink K, de Taeye A, Müller R, Kiefer P, Yagmur E, Weber C, Kelm M, Hoffmann R.

Thromb Haemost. 2007 Dec;98(6):1329-34.

PMID:
18064332
[PubMed - indexed for MEDLINE]
8.

A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.

Jakubowski JA, Payne CD, Li YG, Farid NA, Brandt JT, Small DS, Salazar DE, Winters KJ.

Thromb Haemost. 2008 Jan;99(1):215-22. doi: 10.1160/TH07-09-0555.

PMID:
18217157
[PubMed - indexed for MEDLINE]
9.

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation.

Barragan P, Bouvier JL, Roquebert PO, Macaluso G, Commeau P, Comet B, Lafont A, Camoin L, Walter U, Eigenthaler M.

Catheter Cardiovasc Interv. 2003 Jul;59(3):295-302.

PMID:
12822144
[PubMed - indexed for MEDLINE]
10.

Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.

Hochholzer W, Trenk D, Fromm MF, Valina CM, Stratz C, Bestehorn HP, Büttner HJ, Neumann FJ.

J Am Coll Cardiol. 2010 Jun 1;55(22):2427-34. doi: 10.1016/j.jacc.2010.02.031.

PMID:
20510210
[PubMed - indexed for MEDLINE]
Free Article
11.

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases.

Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C.

J Thromb Haemost. 2005 Jan;3(1):85-92.

PMID:
15634270
[PubMed - indexed for MEDLINE]
12.

Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.

Metzler H, Prüller F, Münch A, Primus G, Kainz J, Hödl R, Rehak P.

Eur J Anaesthesiol. 2010 Feb;27(2):138-45. doi: 10.1097/EJA.0b013e32832eb521.

PMID:
19593147
[PubMed - indexed for MEDLINE]
13.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, Mansourati J, Mottier D, Abgrall JF, Boschat J.

J Am Coll Cardiol. 2008 Jan 22;51(3):256-60. doi: 10.1016/j.jacc.2007.06.064.

PMID:
18206732
[PubMed - indexed for MEDLINE]
Free Article
14.

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.

Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, Simeoni MC, Barragan P, Dignat-George F, Paganelli F.

J Am Coll Cardiol. 2008 Apr 8;51(14):1404-11. doi: 10.1016/j.jacc.2007.12.044.

PMID:
18387444
[PubMed - indexed for MEDLINE]
Free Article
15.

Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay.

Siller-Matula JM, Christ G, Lang IM, Delle-Karth G, Huber K, Jilma B.

J Thromb Haemost. 2010 Feb;8(2):351-9. doi: 10.1111/j.1538-7836.2009.03699.x. Epub 2009 Nov 23.

PMID:
19943879
[PubMed - indexed for MEDLINE]
16.

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.

Michelson AD, Frelinger AL 3rd, Braunwald E, Downey WE, Angiolillo DJ, Xenopoulos NP, Jakubowski JA, Li Y, Murphy SA, Qin J, McCabe CH, Antman EM, Wiviott SD; TRITON-TIMI 38 Investigators.

Eur Heart J. 2009 Jul;30(14):1753-63. doi: 10.1093/eurheartj/ehp159. Epub 2009 May 12.

PMID:
19435740
[PubMed - indexed for MEDLINE]
Free Article
17.

Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.

Cuisset T, Frere C, Quilici J, Gaborit B, Castelli C, Poyet R, Bali L, Morange PE, Alessi MC, Bonnet JL.

Am J Cardiol. 2009 Oct 15;104(8):1078-82. doi: 10.1016/j.amjcard.2009.06.007.

PMID:
19801028
[PubMed - indexed for MEDLINE]
18.

The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.

Thromb Res. 2011 Oct;128(4):352-7. doi: 10.1016/j.thromres.2011.05.008. Epub 2011 May 28.

PMID:
21621250
[PubMed - indexed for MEDLINE]
19.

Clopidogrel and calcium-channel antagonists: another drug-drug interaction for the ever-wary clinician?

Kleiman NS.

J Am Coll Cardiol. 2008 Nov 4;52(19):1564-6. doi: 10.1016/j.jacc.2008.08.011. No abstract available.

PMID:
19007593
[PubMed - indexed for MEDLINE]
Free Article
20.

The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation.

Siller-Matula JM, Haberl K, Prillinger K, Panzer S, Lang I, Jilma B.

Thromb Res. 2009 Apr;123(6):874-80. doi: 10.1016/j.thromres.2008.11.005. Epub 2009 Jan 9.

PMID:
19135705
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk